Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma

Aims Bile salt export pump (BSEP) is a transporter expressed exclusively at hepatic canaliculi and drives bile‐salt efflux. Minimal data exist about BSEP expression in tumours. We hypothesized that BSEP immunohistochemistry would be specific for hepatocellular carcinoma (HCC). Methods and results Ti...

Full description

Saved in:
Bibliographic Details
Published inHistopathology Vol. 66; no. 4; pp. 598 - 602
Main Authors Lagana, Stephen M, Salomao, Marcela, Remotti, Helen E, Knisely, A.S., Moreira, Roger K
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.03.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aims Bile salt export pump (BSEP) is a transporter expressed exclusively at hepatic canaliculi and drives bile‐salt efflux. Minimal data exist about BSEP expression in tumours. We hypothesized that BSEP immunohistochemistry would be specific for hepatocellular carcinoma (HCC). Methods and results Tissue microarrays, including 48 HCC, 41 cholangiocarcinomas and 24 metastatic tumours in liver, were immunostained for BSEP. Expression was compared with common markers of hepatocytic differentiation including CD10, hepatocyte paraffin‐1 antigen (HepPar‐1), carcinoembryonic antigen, arginase‐1 (ARG) and glypican‐3 (GPC‐3). BSEP expression was assessed in normal tissues. Special attention was given to adrenal gland (normal and neoplasia). BSEP was easy to interpret and showed no background staining. Canalicular expression was seen in all normal livers, but not in other normal tissue. BSEP was 90% sensitive and 100% specific for HCC (canalicular in 33 of 43 positive cases). The sensitivity of ARG was slightly higher, but specificity was slightly lower (94% for both). HepPar‐1 was 90% sensitive and 97% specific. CD10, polyclonal carcinoembryonic antigen (pCEA) and GPC‐3 all had lower sensitivity (74, 81 and 54%, respectively). Conclusions In malignant tumours in the liver, BSEP marking was 100% specific and 90% sensitive for HCC. The specificity of BSEP for HCC obviates the need to identify a ‘canalicular’ pattern, which can limit the utility of other canalicular markers.
AbstractList Bile salt export pump (BSEP) is a transporter expressed exclusively at hepatic canaliculi and drives bile-salt efflux. Minimal data exist about BSEP expression in tumours. We hypothesized that BSEP immunohistochemistry would be specific for hepatocellular carcinoma (HCC). Tissue microarrays, including 48 HCC, 41 cholangiocarcinomas and 24 metastatic tumours in liver, were immunostained for BSEP. Expression was compared with common markers of hepatocytic differentiation including CD10, hepatocyte paraffin-1 antigen (HepPar-1), carcinoembryonic antigen, arginase-1 (ARG) and glypican-3 (GPC-3). BSEP expression was assessed in normal tissues. Special attention was given to adrenal gland (normal and neoplasia). BSEP was easy to interpret and showed no background staining. Canalicular expression was seen in all normal livers, but not in other normal tissue. BSEP was 90% sensitive and 100% specific for HCC (canalicular in 33 of 43 positive cases). The sensitivity of ARG was slightly higher, but specificity was slightly lower (94% for both). HepPar-1 was 90% sensitive and 97% specific. CD10, polyclonal carcinoembryonic antigen (pCEA) and GPC-3 all had lower sensitivity (74, 81 and 54%, respectively). In malignant tumours in the liver, BSEP marking was 100% specific and 90% sensitive for HCC. The specificity of BSEP for HCC obviates the need to identify a 'canalicular' pattern, which can limit the utility of other canalicular markers.
Aims Bile salt export pump (BSEP) is a transporter expressed exclusively at hepatic canaliculi and drives bile‐salt efflux. Minimal data exist about BSEP expression in tumours. We hypothesized that BSEP immunohistochemistry would be specific for hepatocellular carcinoma (HCC). Methods and results Tissue microarrays, including 48 HCC, 41 cholangiocarcinomas and 24 metastatic tumours in liver, were immunostained for BSEP. Expression was compared with common markers of hepatocytic differentiation including CD10, hepatocyte paraffin‐1 antigen (HepPar‐1), carcinoembryonic antigen, arginase‐1 (ARG) and glypican‐3 (GPC‐3). BSEP expression was assessed in normal tissues. Special attention was given to adrenal gland (normal and neoplasia). BSEP was easy to interpret and showed no background staining. Canalicular expression was seen in all normal livers, but not in other normal tissue. BSEP was 90% sensitive and 100% specific for HCC (canalicular in 33 of 43 positive cases). The sensitivity of ARG was slightly higher, but specificity was slightly lower (94% for both). HepPar‐1 was 90% sensitive and 97% specific. CD10, polyclonal carcinoembryonic antigen (pCEA) and GPC‐3 all had lower sensitivity (74, 81 and 54%, respectively). Conclusions In malignant tumours in the liver, BSEP marking was 100% specific and 90% sensitive for HCC. The specificity of BSEP for HCC obviates the need to identify a ‘canalicular’ pattern, which can limit the utility of other canalicular markers.
Aims Bile salt export pump (BSEP) is a transporter expressed exclusively at hepatic canaliculi and drives bile-salt efflux. Minimal data exist about BSEP expression in tumours. We hypothesized that BSEP immunohistochemistry would be specific for hepatocellular carcinoma (HCC). Methods and results Tissue microarrays, including 48 HCC, 41 cholangiocarcinomas and 24 metastatic tumours in liver, were immunostained for BSEP. Expression was compared with common markers of hepatocytic differentiation including CD10, hepatocyte paraffin-1 antigen (HepPar-1), carcinoembryonic antigen, arginase-1 (ARG) and glypican-3 (GPC-3). BSEP expression was assessed in normal tissues. Special attention was given to adrenal gland (normal and neoplasia). BSEP was easy to interpret and showed no background staining. Canalicular expression was seen in all normal livers, but not in other normal tissue. BSEP was 90% sensitive and 100% specific for HCC (canalicular in 33 of 43 positive cases). The sensitivity of ARG was slightly higher, but specificity was slightly lower (94% for both). HepPar-1 was 90% sensitive and 97% specific. CD10, polyclonal carcinoembryonic antigen (pCEA) and GPC-3 all had lower sensitivity (74, 81 and 54%, respectively). Conclusions In malignant tumours in the liver, BSEP marking was 100% specific and 90% sensitive for HCC. The specificity of BSEP for HCC obviates the need to identify a 'canalicular' pattern, which can limit the utility of other canalicular markers.
Author Remotti, Helen E
Salomao, Marcela
Knisely, A.S.
Moreira, Roger K
Lagana, Stephen M
Author_xml – sequence: 1
  givenname: Stephen M
  surname: Lagana
  fullname: Lagana, Stephen M
  email: sml2179@cumc.columbia.edu
  organization: Department of Pathology and Cell Biology, Columbia University/New York Presbyterian Hospital, NY, New York, USA
– sequence: 2
  givenname: Marcela
  surname: Salomao
  fullname: Salomao, Marcela
  organization: Department of Pathology and Cell Biology, Columbia University/New York Presbyterian Hospital, NY, New York, USA
– sequence: 3
  givenname: Helen E
  surname: Remotti
  fullname: Remotti, Helen E
  organization: Department of Pathology and Cell Biology, Columbia University/New York Presbyterian Hospital, NY, New York, USA
– sequence: 4
  givenname: A.S.
  surname: Knisely
  fullname: Knisely, A.S.
  organization: Institute of Liver Studies, King's College Hospital, London, UK
– sequence: 5
  givenname: Roger K
  surname: Moreira
  fullname: Moreira, Roger K
  organization: Department of Pathology, Mayo Clinic, MN, Rochester, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25378077$$D View this record in MEDLINE/PubMed
BookMark eNp1kD1PwzAQhi0EgvIx8AeQJSaGFDuXxJSNFmiREAyAQCyW65xVQxIHO-Hj32MosHGLh3vuPd-zSVYb1yAhu5wNeazDhQ1DnhaMr5ABhyJP0jwfrZIBAzZKGC_EBtkM4YkxLiBN18lGmoM4YkIMiBnbCmlQVUfxvXW-o21ft8dU0YBNsJ19RaqakoYWtTVWU1vXfePixs7pBdZWq4rWyj-jp87QBbYqNrCq-kp5qpXXtnG12iZrRlUBd37eLXJ3fnY7mSWX19OLycllorNRxpNybozOIAUm-JxnQqQYf8lYphjkHJgqSgQ14gyUgqwUZaGNxhK5EcVRqQxskf1lbuvdS4-hk0-u901cKXmRp8CzHCBSB0tKexeCRyNbb-MRH5Iz-WVUxvvkt9HI7v0k9vMayz_yV2EEDpfAWzT58X-SnF3c_EYmy4koEd__JqJEWQgQuby_msqrm8dTMXsYyzF8AiZbkeQ
CODEN HISTDD
CitedBy_id crossref_primary_10_3390_biomedicines11092582
crossref_primary_10_5858_arpa_2022_0462_RA
crossref_primary_10_1007_s00292_018_0565_0
crossref_primary_10_3390_cells9020498
crossref_primary_10_1038_s41598_021_82636_z
crossref_primary_10_1186_s13287_020_02113_8
crossref_primary_10_3748_wjg_v25_i40_6041
crossref_primary_10_3390_diagnostics9040167
crossref_primary_10_3390_ijms22020784
crossref_primary_10_1097_PAP_0000000000000139
crossref_primary_10_1016_j_path_2018_02_004
crossref_primary_10_1007_s12253_018_0386_8
crossref_primary_10_1016_j_humpath_2017_09_007
crossref_primary_10_1016_j_jhep_2015_06_015
crossref_primary_10_1177_1093526618806750
crossref_primary_10_1093_ajcp_aqz032
crossref_primary_10_1016_j_path_2023_04_012
crossref_primary_10_3390_diagnostics11122351
crossref_primary_10_1097_PAP_0000000000000227
crossref_primary_10_1097_PAS_0000000000000585
crossref_primary_10_3389_fmed_2017_00010
crossref_primary_10_1016_j_humpath_2016_12_025
crossref_primary_10_1097_MD_0000000000019159
crossref_primary_10_1038_s41416_021_01363_4
crossref_primary_10_4254_wjh_v7_i10_1403
Cites_doi 10.1080/00313020701716391
10.1016/S0002-9440(10)62528-X
10.1158/1078-0432.CCR-05-0278
10.1016/S0016-5085(03)00689-9
10.1097/PAI.0b013e3182642c9c
10.1309/KC09YTF2M4DLUYQ6
10.1097/PAS.0b013e3181e5dffa
10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
10.1309/AJCPUD0P5NQBOYPK
10.1016/j.acthis.2011.10.003
10.1038/3034
10.1097/00000658-199909000-00004
10.1038/labinvest.3700699
10.1001/archsurg.141.10.1000
10.1186/1746-1596-7-149
ContentType Journal Article
Copyright 2014 John Wiley & Sons Ltd
2014 John Wiley & Sons Ltd.
Copyright © 2015 John Wiley & Sons Ltd
Copyright_xml – notice: 2014 John Wiley & Sons Ltd
– notice: 2014 John Wiley & Sons Ltd.
– notice: Copyright © 2015 John Wiley & Sons Ltd
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7QR
7T5
7TK
7TM
8FD
FR3
H94
P64
RC3
DOI 10.1111/his.12601
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Genetics Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
DatabaseTitleList MEDLINE

Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2559
EndPage 602
ExternalDocumentID 3583642121
10_1111_his_12601
25378077
HIS12601
ark_67375_WNG_NSZD7HXB_B
Genre shortCommunication
Journal Article
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
29I
31~
33P
36B
3SF
3UE
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
GSXLS
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
J5H
K48
KBYEO
L7B
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
Y6R
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
ACRPL
ACYXJ
CITATION
7QP
7QR
7T5
7TK
7TM
8FD
FR3
H94
P64
RC3
ID FETCH-LOGICAL-c4941-dbffc4323071b14772e077004a035130a6de3a9103aa34d7d6cfcede1f768daf3
IEDL.DBID DR2
ISSN 0309-0167
IngestDate Thu Oct 10 19:59:12 EDT 2024
Fri Dec 06 01:51:46 EST 2024
Sat Sep 28 08:49:18 EDT 2024
Sat Aug 24 00:52:00 EDT 2024
Wed Oct 30 09:53:28 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords bile salt export pump
hepatocellular carcinoma
immunohistochemistry
Language English
License 2014 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4941-dbffc4323071b14772e077004a035130a6de3a9103aa34d7d6cfcede1f768daf3
Notes ark:/67375/WNG-NSZD7HXB-B
istex:0166AF143C3A078753F562AB97216B1413308E92
ArticleID:HIS12601
PMID 25378077
PQID 1652314533
PQPubID 1086360
PageCount 5
ParticipantIDs proquest_journals_1652314533
crossref_primary_10_1111_his_12601
pubmed_primary_25378077
wiley_primary_10_1111_his_12601_HIS12601
istex_primary_ark_67375_WNG_NSZD7HXB_B
PublicationCentury 2000
PublicationDate March 2015
PublicationDateYYYYMMDD 2015-03-01
PublicationDate_xml – month: 03
  year: 2015
  text: March 2015
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Histopathology
PublicationTitleAlternate Histopathology
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Capurro M, Wanless IR, Sherman M et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003; 125; 89-97.
Edmondson HASP. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7; 462-503.
Musunuru S, Chen H, Rajpal S et al. Metastatic neuroendocrine hepatic tumors: resection improves survival. Arch. Surg. 2006; 141; 1000-1004; discussion 5.
Knisely A. Hepatocellular carcinoma, renal cell carcinoma metastatic to liver, and adrenal carcinoma metastatic to liver: immunostaining for bile salt export pump as a marker of hepatocellular differentiation. Lab. Invest. 2009; 89(Suppl. 1); 312A-313A.
Gulluoglu MG, Karayigit E, Ozden I, Kapran Y, Dizdaroglu F. Does HepPar-1 immunoexpression have a role in differential diagnosis of periampullary cancer? Pathology 2008; 40; 35-41.
Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. Am. J. Pathol. 1993; 143; 1050-1054.
Strautnieks SS, Bull LN, Knisely AS et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 1998; 20; 233-238.
Fan Z, Li J, Dong B, Huang X. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis. Clin. Cancer Res. 2005; 11; 6162-6170.
Butler SL, Dong H, Cardona D et al. The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1. Lab. Invest. 2008; 88; 78-88.
Radwan NA, Ahmed NS. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1. Diagn. Pathol. 2012; 7; 149.
Lugli A, Tornillo L, Mirlacher M, Bundi M, Sauter G, Terracciano LM. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples. Am. J. Clin. Pathol. 2004; 122; 721-727.
Yan BC, Gong C, Song J et al. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am. J. Surg. Pathol. 2010; 34; 1147-1154.
Mac MT, Chung F, Lin F, Hui P, Balzer BL, Wang HL. Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma. Am. J. Clin. Pathol. 2009; 132; 80-85.
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 1999; 230; 309-318; discussion 18-21.
Xiao SY, Wang HL, Hart J, Fleming D, Beard MR. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. Am. J. Pathol. 2001; 159; 1415-1421.
Lagana SM, Hsiao S, Bao F et al. HepPar-1 and arginase-1 in small intestinal and ampullary adenocarcinoma. Virchows Arch. 2013; 463; 148-149.
Lagana SM, Moreira RK, Remotti HE, Bao F. Glutamine synthetase, heat shock protein-70, and glypican-3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver. Appl. Immunohistochem. Mol. Morphol. 2013; 21; 254-257.
Zhang L, Liu H, Sun L, Li N, Ding H, Zheng J. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study. Acta Histochem. 2012; 114; 547-552.
2010; 34
2009; 89
2004; 122
2013; 21
2009; 132
1999; 230
2006; 141
2013; 463
1954; 7
2008; 88
2014
2012; 114
2003; 125
2008; 40
2012; 7
1998; 20
1993; 143
2001; 159
2005; 11
Knisely A (e_1_2_6_10_1) 2009; 89
Wennerberg AE (e_1_2_6_2_1) 1993; 143
e_1_2_6_9_1
e_1_2_6_8_1
Lagana SM (e_1_2_6_7_1) 2013; 21
e_1_2_6_19_1
Lagana SM (e_1_2_6_20_1) 2013; 463
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_6_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – volume: 230
  start-page: 309
  year: 1999
  end-page: 318
  article-title: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases
  publication-title: Ann. Surg.
– volume: 122
  start-page: 721
  year: 2004
  end-page: 727
  article-title: Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples
  publication-title: Am. J. Clin. Pathol.
– volume: 141
  start-page: 1000
  year: 2006
  end-page: 1004
  article-title: Metastatic neuroendocrine hepatic tumors: resection improves survival
  publication-title: Arch. Surg.
– volume: 20
  start-page: 233
  year: 1998
  end-page: 238
  article-title: A gene encoding a liver‐specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
  publication-title: Nat. Genet.
– volume: 125
  start-page: 89
  year: 2003
  end-page: 97
  article-title: Glypican‐3: a novel serum and histochemical marker for hepatocellular carcinoma
  publication-title: Gastroenterology
– volume: 132
  start-page: 80
  year: 2009
  end-page: 85
  article-title: Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma
  publication-title: Am. J. Clin. Pathol.
– volume: 7
  start-page: 149
  year: 2012
  article-title: The diagnostic value of arginase‐1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar‐1
  publication-title: Diagn. Pathol.
– volume: 463
  start-page: 148
  year: 2013
  end-page: 149
  article-title: HepPar‐1 and arginase‐1 in small intestinal and ampullary adenocarcinoma
  publication-title: Virchows Arch.
– volume: 7
  start-page: 462
  year: 1954
  end-page: 503
  article-title: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies
  publication-title: Cancer
– volume: 143
  start-page: 1050
  year: 1993
  end-page: 1054
  article-title: Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors
  publication-title: Am. J. Pathol.
– volume: 34
  start-page: 1147
  year: 2010
  end-page: 1154
  article-title: Arginase‐1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms
  publication-title: Am. J. Surg. Pathol.
– volume: 88
  start-page: 78
  year: 2008
  end-page: 88
  article-title: The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1
  publication-title: Lab. Invest.
– volume: 11
  start-page: 6162
  year: 2005
  end-page: 6170
  article-title: Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis
  publication-title: Clin. Cancer Res.
– volume: 40
  start-page: 35
  year: 2008
  end-page: 41
  article-title: Does HepPar‐1 immunoexpression have a role in differential diagnosis of periampullary cancer?
  publication-title: Pathology
– volume: 114
  start-page: 547
  year: 2012
  end-page: 552
  article-title: Glypican‐3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray‐based study
  publication-title: Acta Histochem.
– volume: 21
  start-page: 254
  year: 2013
  end-page: 257
  article-title: Glutamine synthetase, heat shock protein‐70, and glypican‐3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver
  publication-title: Appl. Immunohistochem. Mol. Morphol.
– volume: 159
  start-page: 1415
  year: 2001
  end-page: 1421
  article-title: cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma
  publication-title: Am. J. Pathol.
– year: 2014
– volume: 89
  start-page: 312A
  issue: Suppl. 1
  year: 2009
  end-page: 313A
  article-title: Hepatocellular carcinoma, renal cell carcinoma metastatic to liver, and adrenal carcinoma metastatic to liver: immunostaining for bile salt export pump as a marker of hepatocellular differentiation
  publication-title: Lab. Invest.
– ident: e_1_2_6_13_1
  doi: 10.1080/00313020701716391
– ident: e_1_2_6_3_1
  doi: 10.1016/S0002-9440(10)62528-X
– volume: 89
  start-page: 312A
  issue: 1
  year: 2009
  ident: e_1_2_6_10_1
  article-title: Hepatocellular carcinoma, renal cell carcinoma metastatic to liver, and adrenal carcinoma metastatic to liver: immunostaining for bile salt export pump as a marker of hepatocellular differentiation
  publication-title: Lab. Invest.
  contributor:
    fullname: Knisely A
– ident: e_1_2_6_14_1
  doi: 10.1158/1078-0432.CCR-05-0278
– ident: e_1_2_6_5_1
  doi: 10.1016/S0016-5085(03)00689-9
– volume: 21
  start-page: 254
  year: 2013
  ident: e_1_2_6_7_1
  article-title: Glutamine synthetase, heat shock protein‐70, and glypican‐3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver
  publication-title: Appl. Immunohistochem. Mol. Morphol.
  doi: 10.1097/PAI.0b013e3182642c9c
  contributor:
    fullname: Lagana SM
– ident: e_1_2_6_16_1
  doi: 10.1309/KC09YTF2M4DLUYQ6
– ident: e_1_2_6_4_1
  doi: 10.1097/PAS.0b013e3181e5dffa
– ident: e_1_2_6_11_1
  doi: 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
– volume: 143
  start-page: 1050
  year: 1993
  ident: e_1_2_6_2_1
  article-title: Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors
  publication-title: Am. J. Pathol.
  contributor:
    fullname: Wennerberg AE
– volume: 463
  start-page: 148
  year: 2013
  ident: e_1_2_6_20_1
  article-title: HepPar‐1 and arginase‐1 in small intestinal and ampullary adenocarcinoma
  publication-title: Virchows Arch.
  contributor:
    fullname: Lagana SM
– ident: e_1_2_6_8_1
– ident: e_1_2_6_15_1
  doi: 10.1309/AJCPUD0P5NQBOYPK
– ident: e_1_2_6_6_1
  doi: 10.1016/j.acthis.2011.10.003
– ident: e_1_2_6_9_1
  doi: 10.1038/3034
– ident: e_1_2_6_18_1
  doi: 10.1097/00000658-199909000-00004
– ident: e_1_2_6_12_1
  doi: 10.1038/labinvest.3700699
– ident: e_1_2_6_19_1
  doi: 10.1001/archsurg.141.10.1000
– ident: e_1_2_6_17_1
  doi: 10.1186/1746-1596-7-149
SSID ssj0017322
Score 2.3309243
Snippet Aims Bile salt export pump (BSEP) is a transporter expressed exclusively at hepatic canaliculi and drives bile‐salt efflux. Minimal data exist about BSEP...
Bile salt export pump (BSEP) is a transporter expressed exclusively at hepatic canaliculi and drives bile-salt efflux. Minimal data exist about BSEP expression...
Aims Bile salt export pump (BSEP) is a transporter expressed exclusively at hepatic canaliculi and drives bile-salt efflux. Minimal data exist about BSEP...
SourceID proquest
crossref
pubmed
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 598
SubjectTerms Aged
Antigens
ATP Binding Cassette Subfamily B Member 11
ATP-Binding Cassette Transporters - metabolism
Bile
Bile Duct Neoplasms - diagnosis
Bile Duct Neoplasms - metabolism
Bile Duct Neoplasms - pathology
Bile Ducts, Intrahepatic - metabolism
Bile Ducts, Intrahepatic - pathology
bile salt export pump
Biomarkers, Tumor - metabolism
Carcinoma, Hepatocellular - diagnosis
Carcinoma, Hepatocellular - metabolism
Carcinoma, Hepatocellular - pathology
Cholangiocarcinoma - diagnosis
Cholangiocarcinoma - metabolism
Cholangiocarcinoma - pathology
Diagnosis, Differential
Female
hepatocellular carcinoma
Humans
Immunohistochemistry
Liver cancer
Liver Neoplasms - diagnosis
Liver Neoplasms - metabolism
Liver Neoplasms - pathology
Male
Middle Aged
Sensitivity and Specificity
Tumors
Title Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma
URI https://api.istex.fr/ark:/67375/WNG-NSZD7HXB-B/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhis.12601
https://www.ncbi.nlm.nih.gov/pubmed/25378077
https://www.proquest.com/docview/1652314533
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3faxQxEB5KC-KLv7WrtQQR8WWPzSW72dWnrud5Cr0Ha_EQYUk2CS1e90rvCsW_3pnsD60oiG8Lmw2ZTCb5ZvPlC8DzRBo-tpimIhouYkkimLk0aaxtrkzqldPB04fzbHYsPyzSxRa87s_CtPoQww83iowwX1OAa7P-JchPTtcjToJYOP9yoYjON_k4SEdxJX7uIBDVvlMVIhbP8OW1tWiHuvXqT0DzOm4NC8_0Nnztm9zyTb6NLjdmVH__Tc3xP226A7c6QMoO2hF0F7Zccw9uHHZb7vfBl1gTW-vlhrkrAuvsHEfAK6bZmrjvNFsy3VhGRzaJdsRO6cTJKugY150aATsjEtAFW3l2gssfvnDLJfFfWU1XGTWrM_0AjqdvP72Zxd3lDHEtC8lja7yvpSAeOTdcIkh3iSKtfE17kyLRmXVCIxgRWgtplc1qXzvruMcEx2ovHsJ2s2rcLrDEqCKVY6OSzMkir43QTqY2K8Yq9zZzETzr3VSdtxocVZ-7oDVV6LEIXgQHDiXQMCKtqbT6PH9XzY--TNRsUVZlBHu9h6suXrGKDBNyLhH7RvCo9fpQ0TgVKkfbIngZfPf3NlSz90fh4fG_F30CNxGDpS2tbQ-2NxeX7ininI3Zh52DclJO98PA_gER-PkS
link.rule.ids 314,780,784,1375,27924,27925,46294,46718
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1daxQxFL3UFtQX67djqwYR8WWWySYzmRFfuq11qt19sC0uBQnJJKHF7WzpbqH4683NfGhFQXwbmJmQm5ubnJucnAC8SrimQ-PTVI-Gi5ijCGbOdRorkwudOmFV8PR4kpVH_OM0na7Au-4sTKMP0S-4YWSE8RoDHBekf4nyk9PFgKIi1g1Y8-FOkdC187kXj6KC_dxDQLJ9qyuEPJ7-12uz0Ro27NWfoOZ15Bqmnt11-NpVumGcfBtcLvWg-v6bnuP_WnUX7rSYlGw1negerNj6Ptwct7vuD8CNfFFkoWZLYq8Qr5Nz3wneEkUWSH_HAZOo2hA8tYnMI3KKh07mQcq4agUJyBnygC7I3JETPwP6F3Y2QwosqfA2o3p-ph7C0e77w-0ybu9niCtecBob7VzFGVLJqabc43SbCJTLV7g9yRKVGcuUxyNMKcaNMFnlKmssdT7HMcqxR7Baz2v7BEiiRZHyoRZJZnmRV5opy1OTFUORO5PZCF52fpLnjQyH7NIXb40MLRbB6-DB_gtvGPLWRCq_TD7IycHxjiinIzmKYLNzsWxD1heR-Zyccg9_I3jcuL0vaJgykXvbIngTnPf3Oshy7yA8PP33T1_ArfJwvC_39yafNuC2h2Rpw3LbhNXlxaV95mHPUj8PvfsH02T7wQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1daxQxFL3UFoovVuvX1FqDiPgyy8wkM5mxT27XdWvbRazFRYSQTBJa3M4u3S2U_npzMx9aUZC-DUwm5ObmJudOTk4AXkVMxYl2aapDw0XIUAQzZyoNpc65Si030nv6aJyNTtjHSTpZgd32LEytD9H9cMPI8PM1Bvhc29-C_PRs0YtREOsOrLEsKVA4f_C5046KOf21hYBc-0ZWCGk83ac3FqM17NervyHNm8DVrzzDDfjetrkmnPzoXS5Vr7z-Q87xlkbdh3sNIiXv6iH0AFZMtQnrR82e-0OwfVcTWcjpkpgrROtk7obAWyLJAsnvOF0SWWmCZzaRd0TO8MjJzAsZl40cATlHFtAFmVly6tY_98JMp0iAJSXeZVTNzuUjOBm-_7I3CpvbGcKSFSwOtbK2ZBSJ5LGKmUPpJuIoli9xc5JGMtOGSodGqJSUaa6z0pZGm9i6DEdLSx_DajWrzFMgkeJFyhLFo8ywIi8VlYalOisSnludmQBetm4S81qEQ7TJi7NG-B4L4LV3YFfCGYasNZ6Kr-MPYnz8bcBHk77oB7Ddelg0AeuqyFxGHjMHfgN4Unu9qyhJKc-dbQG88b77dxvEaP_YP2z9f9EXsP5pMBSH--ODZ3DX4bG0prhtw-ry4tI8d5hnqXb82P4J6Or6cA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bile+salt+export+pump%3A+a+sensitive+and+specific+immunohistochemical+marker+of+hepatocellular+carcinoma&rft.jtitle=Histopathology&rft.au=Lagana%2C+Stephen+M&rft.au=Salomao%2C+Marcela&rft.au=Remotti%2C+Helen+E&rft.au=Knisely%2C+A.S.&rft.date=2015-03-01&rft.issn=0309-0167&rft.eissn=1365-2559&rft.volume=66&rft.issue=4&rft.spage=598&rft.epage=602&rft_id=info:doi/10.1111%2Fhis.12601&rft.externalDBID=10.1111%252Fhis.12601&rft.externalDocID=HIS12601
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0309-0167&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0309-0167&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0309-0167&client=summon